▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

FillPoint Health, a Lyceum Health Company, Announces Exclusive Specialty Pharmacy Partnership with US Heart & Vascular

FillPoint Health, a leading specialty pharmacy and MSO platform under Lyceum Health, is proud to announce an exclusive partnership with US Heart & Vascular (USHV), the nation’s premier cardiovas...

Immagine

DUBLIN, Ohio: FillPoint Health, a leading specialty pharmacy and MSO platform under Lyceum Health, is proud to announce an exclusive partnership with US Heart & Vascular (USHV), the nation’s premier cardiovascular management services organization, to streamline access, dispensing, and patient support services for innovative RNA interference (RNAi) therapies for rare, inherited disorders in cardiovascular disease.

This collaboration marks a significant step in enhancing the care pathway for patients with complex cardiovascular and rare disease conditions by integrating clinical prescribing, specialty fulfillment, and real-time patient engagement through a unified provider-pharmacy model.

“This exclusive partnership aligns perfectly with our mission to bridge the gap between provider care and specialty therapy access,” said Michael Baldzicki, Chief Revenue Officer of Lyceum Health, A Group of Companies (RxNexus & FillPoint Health). “Together with US Heart & Vascular, we’re enabling earlier intervention, better adherence, and improved outcomes for a highly targeted patient population.”

Key Highlights of the Partnership:

  • Exclusive dispensing rights through FillPoint Health for USHV providers
  • Seamless coordination of prior authorizations, benefit navigation, and patient onboarding for pharmacy services
  • Real-time provider visibility, patient adherence tracking, and reporting.

“USHV is committed to delivering next-generation cardiovascular care,” said Emily Rash, Chief Operating Officer at USHV. “This partnership allows our physicians to focus on clinical care while ensuring their patients receive uninterrupted access to life-changing therapies. These advanced capabilities allow USHV partners to deliver the right therapy to the right patient at the right time.”

Through this collaboration, FillPoint Health leverages its specialty pharmacy infrastructure and digital capabilities to improve therapy access at the point of care-supporting physicians and patients with high-touch, precision-based services.

About FillPoint Health

FillPoint Health is a licensed and accredited specialty pharmacy and MSO platform under Lyceum Health, focused on enabling integrated care for complex and rare conditions. Through its national network, proprietary RxNexus platform, and Therapeutic Engagement Centers (TEC), FillPoint streamlines specialty prescribing, distribution, and outcomes-driven patient support. Visit FillPointHealth.com.

About US Heart & Vascular (USHV)

USHV is a leading national cardiovascular physician platform dedicated to supporting world-class care through clinical innovation, operational efficiency, and strategic partnerships across its growing network of practices. Visit USHeartandVascular.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Arkose Labs Report Exposes Evolving Cybercriminal Tactics Including Agentic…

#bot--Arkose Labs, the leading fraud prevention, device ID and bot management company, has published "Enterprises Under Attack: Quarterly Threat Actor…

Validation of FDA-Regulated Systems Used in Drug Development & Submissions…

The "Validation of FDA-Regulated Systems Used in Drug Development & Submissions Using Artificial Intelligence (AI), Machine Learning (ML) & Large…

26th UN Tourism General Assembly kicks off in Riyadh

The 26th session of the UN Tourism General Assembly opened today in Riyadh, marking a historic first for the Gulf Cooperation Council (GCC) region and…

OMRON Releases the “Medium-Term Roadmap SF 2nd Stage”

OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!